LBO — CIVISTA MEDICAL CENTER
IRR: 28.7% | MOIC: 3.53x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
28.7%
IRR
3.53x
MOIC
$46.6M
Entry EV
$107.3M
Exit EV
$24.0M
Equity Invested
Sources & Uses
S&UTotal · $46.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $18.1M | 38.8% | |
| Sub Debt | $4.5M | 9.7% | |
| Equity | $24.0M | 51.5% | |
| Enterprise Value | $45.3M | 97.1% | |
| Transaction Fees | $1.4M | 2.9% | |
| Total Uses | $46.6M | 100.0% |
Interpretation
INTAt 3.53x MOIC and 28.7% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $10.2M |
| Exit Ev | $107.3M |
| Net Debt At Exit | $22.5M |
| Equity At Exit | $84.8M |
| Equity Invested | $24.0M |
| Total Value Created | $60.8M |
| Value From Growth | $59.8M |
| Value From Multiple | $2.3M |
| Value From Deleveraging | $0.2M |